To test this hypothesis, we used cBioPortal.org (Cerami et al., 2012; Gao et al., 2013) to analyze the overall survival of CRC patients with and without RPTOR mutations using a provisional TCGA cohort (n = 633) (Fig. S2B) (Available at: http://bit.ly/2tbMjVk). Here, RPTOR is linked to colorectal carcinoma.